Channel
@Gastroenterology_Updates
On this record: Growth · Engagement · Reactions · Posts · Citations · Telegram's recommendations · Cite this entry
4,856subscribers
+96 since we began measuring on 20 August 2026
Risers and fallers across the register · movement among entries of 3,162–10,000.
| Telegram ID | -1001300662632 |
|---|---|
| Type | Channel |
| Username | @Gastroenterology_Updates |
| Created | Between 1 March 2018 and 31 July 2021 — estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 20 August 2026 |
| Last confirmed live | 8 September 2026 |
| Measurements held | 7 |
| Confirmed unchanged | 1 time, most recently 8 September 2026 |
| On Telegram | t.me/Gastroenterology_Updates |
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 8 Sept 2026, 13:37 | 4,856 | +28 |
| 3 Sept 2026, 01:45 | 4,828 | +19 |
| 30 Aug 2026, 22:55 | 4,809 | +21 |
| 28 Aug 2026, 02:24 | 4,788 | +10 |
| 24 Aug 2026, 22:03 | 4,778 | +14 |
| 21 Aug 2026, 00:52 | 4,764 | +4 |
| 20 Aug 2026, 18:45 | 4,760 | first reading |
20 posts held, back to 10 June 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 6 August 2026. An engagement rate over an empty window would be a number about nothing.
1 reaction across 1 post, in 1 kind.
| Reaction | Count | Share | Share, drawn |
|---|---|---|---|
| ❤ | 1 | 100.0% |
No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.
Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.
Coverage. Reactions were read on 4 of the 20 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 1 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.
Measured over the 20 most recent posts we hold, published 10 June 2026 to 6 August 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.
[Comment] Progress and prospects in viral hepatitis elimination https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00021-X/fulltext?rss=yes In 2016, the World Health Assembly formally recognised viral hepatitis as a global health concern and adopted the global health sector strategy on viral hepatitis.1 Targets for eliminating viral hepatitis were ambitious: a 90% reduction in the incidence of chroni…
[Comment] The decade that changed hepatocellular carcinoma: shaping a new treatment paradigm https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00044-0/fulltext?rss=yes A decade ago, advances in the systemic treatment of advanced hepatocellular carcinoma had been stalled for some time. Sorafenib, the first multikinase inhibitor used to treat advanced hepatocellular carcinoma, had been approved in 200…
[Comment] Dietary management of gastrointestinal disease: progress over the last decade and opportunities for the next https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00152-4/fulltext?rss=yes Diet is a much sought-after intervention for the management of gastrointestinal disease by both patients and clinicians. The past decade has witnessed a step-change in progress in the quantity and quality of …
[Comment] A decade of transformation in MASLD: from nomenclature to novel therapies https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00087-7/fulltext?rss=yes Over the past decade, metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the leading cause of chronic liver disease worldwide, affecting over 1·27 billion people, with prevalence predicted to continue increasing un…
❤1
[Comment] A decade of progress in cholestatic liver diseases: navigating a new era https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00045-2/fulltext?rss=yes In the past decade, the landscape of cholestatic liver diseases has undergone a profound transformation. Our understanding has moved from a descriptive approach with a basic understanding of pathogenesis of cholestatic liver diseases to recogni…
[Comment] A decade of artificial intelligence in endoscopy: from proof of concept to clinical reality https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00049-X/fulltext?rss=yes A decade ago, artificial intelligence (AI) in gastroenterology remained largely theoretical. Convolutional neural networks had just begun to show promise in image recognition tasks, but clinical applications were limited to s…
[Comment] A decade of diversity, equity, and inclusion in gastroenterology and hepatology: a US perspective https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00092-0/fulltext?rss=yes Over the past decade, the landscape of diversity, equity, and inclusion (DEI) in gastroenterology and hepatology in the USA has evolved; however, substantial gaps remain. There has been marginal movement in the number o…
[Correspondence] Ethnicity, diversity, and inclusion in gastroenterology: from representation to system performance https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00189-5/fulltext?rss=yes In 2023, we described a paradox in gastroenterology: an increasingly ethnically diverse workforce—mostly among trainees and early-career clinicians—alongside leadership structures that did not reflect this diver…
[Correspondence] Therapeutic drift or formulation drift: avoiding misconceptions about rifaximin and antimicrobial resistance in cirrhosis – Authors' reply https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00191-3/fulltext?rss=yes We thank Carmelo Scarpignato and Manuel Romero-Gómez for their thoughtful Correspondence, and we agree on most of the key points made. Rifaximin remains a valuable drug, i…
[Correspondence] Therapeutic drift or formulation drift: avoiding misconceptions about rifaximin and antimicrobial resistance in cirrhosis https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00156-1/fulltext?rss=yes We read with great interest the Viewpoint by Rajiv Jalan and colleagues discussing rifaximin, therapeutic drift, and antimicrobial stewardship in cirrhosis.1 The topic is undoubtedly of ma…
[Comment] A decade in inflammatory bowel disease: progress, plateaus, and perspectives https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00023-3/fulltext?rss=yes Reflecting on the past decade of progress in inflammatory bowel disease (IBD) feels like observing a thunderstorm of scientific and clinical advances. Yet despite this intensity, a definitive cure remains elusive. To appreciate the current …
[Correspondence] The spectrum of steatotic liver disease in the USA https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00122-6/fulltext?rss=yes We read the recent analysis of the spectrum of steatotic liver disease in the USA by Zobair Younossi and colleagues1 with great interest. The study addresses an important question about the impact of alcohol under-reporting; however, we believe that the centr…
Showing the 12 most recent of 20 posts we hold for @Gastroenterology_Updates. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Republishes
Channels on the register whose posts this channel has forwarded.
Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.
Names
Channels on the register whose handles appear in this channel's posts.
A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.
The reverse of the list above, and a different kind of signal. This does not require this channel to have ever been asked about directly — each row below is a channel we DID ask Telegram about, whose Telegram-generated list happened to include this one. A channel can appear here with an empty list above it, because being named by someone else’s query is independent of having been queried itself.
This channel appears in 10 seed channels' Telegram-generated recommendation lists in total. Each is Telegram’s list for THAT channel, not this one — see how this is measured.
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 8 September 2026 — this entry's latest reading, not the date you are reading this.
“Gastroenterology & Hepatology Updates” (@Gastroenterology_Updates), 4,856 subscribers as measured 8 September 2026. Telegram Register, tgregister.com/channel/Gastroenterology_Updates.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.